M1302 – Screening, diagnostic, film digital or digital breast tomosynthesis (3d) mammography results documented and reviewed
HCPCS Level II code · M codes: Medical Services and Quality Measures
HCPCS codeM1302
- Long description
- Screening, diagnostic, film digital or digital breast tomosynthesis (3d) mammography results documented and reviewed
- Short description
- Scrn mam perf rslts doc
- Pricing indicator
00Not separately priced by Part B (bundled, not covered or Part A only)- Medicare coverage
CCarrier judgment – coverage decided by the Medicare contractor- BETOS category
Z2Undefined codes- Added
- January 1, 2024
- Last change
- January 1, 2024 – No change
Frequently asked questions
What is HCPCS code M1302?
M1302 is a HCPCS Level II code for screening, diagnostic, film digital or digital breast tomosynthesis (3d) mammography results documented and reviewed.
Does Medicare cover M1302?
The HCPCS file lists coverage code C: Carrier judgment – coverage decided by the Medicare contractor. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby M codes
- M1294 – Normal blood pressure reading documented, follow-up not required
- M1295 – Patients with a diagnosis or past history of total colectomy or colorectal cancer
- M1296 – Bmi is documented within normal parameters and no follow-up plan is required
- M1297 – Bmi not documented due to medical reason or patient refusal of height or weight measurement
- M1298 – Documentation of patient pregnancy anytime during the measurement period prior to and including the current encounter
- M1299 – Influenza immunization administered or previously received
- M1300 – Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons)
- M1301 – Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy)
- M1303 – Hospice services provided to patient any time during the measurement period
- M1304 – Patient did not receive any pneumococcal conjugate or polysaccharide vaccine on or after their 19th birthday and before the end of the measurement period
- M1305 – Patient received any pneumococcal conjugate or polysaccharide vaccine on or after their 19th birthday and before the end of the measurement period
- M1306 – Patient had anaphylaxis due to the pneumococcal vaccine any time during or before the measurement period
- M1307 – Documentation stating the patient has received or is currently receiving palliative or hospice care
- M1308 – Influenza immunization was not administered, reason not given
- M1309 – Palliative care services provided to patient any time during the measurement period
- M1310 – Patient screened for tobacco use and received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling, pharmacotherapy, or both), if identified as a tobacco user
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.